Says seeing increase in diagnostic testing volumes, interest in overall health. Says off to "very good start" to the year. Says core growth platforms have "strong momentum." Comments taken from Q1 earnings conference call.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABT:
- Abbott Gains on Q1 Beat
- Abbott reports Q1 worldwide Medical Devices sales up 8.5% on reported basis
- Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
- Abbott backs FY23 organic sales growth ‘at least’ high single digits
- Abbott reports Q1 adjusted EPS $1.03, consensus 99c
